Jordan Lake, MD
Enriched profileProfessor, Infectious Diseases; Barbara E. Murray, MD, Distinguished Professor in Internal Medicine Research · University of Texas Health Science Center at Houston
Jordan Lake is Professor, Infectious Diseases; Barbara E. Murray, MD, Distinguished Professor in Internal Medicine Research at University of Texas Health Science Center at Houston. OpenAlex indexes 256 publications with 5,992 citations (h-index 38); ClinicalTrials.gov lists 13 registered studies with this person as an investigator.
Data verified 18 Oct 2026
Overview
Updated 22 Oct 2026
Jordan Lake, M.D., is Professor, Infectious Diseases at University of Texas Health Science Center at Houston. The public record shows 256 publications with 5,992 citations (h-index 38), centered on HIV-related health complications and treatments, HIV/AIDS Research and Interventions, HIV Research and Treatment. It also documents an investigator role on 13 registered clinical trials, industry payments reported by 6 companies, 8 NIH-funded awards (2016–2026).
- Most recent indexed publication: 2026 · HIV medicine
- Top research focus: HIV-related health complications and treatments
- 13 registered trials on ClinicalTrials.gov
- Open Payments reporting from 6 companies
Generated from the cited public record · current as of 22 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 20 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 121.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 22 Oct 2026
Listed as an investigator on 13 registered studies on ClinicalTrials.gov. The most recent:
- Incretin Microdosing for Cardiometabolic Health in People With HIV
Sponsor: The University of Texas Health Science Center, Houston
- A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
Sponsor: Naga P. Chalasani
- Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Industry payments
Updated 22 Oct 2026
6 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year20251 payment
- ViiV Healthcare CompanyProgram year20258 payments
- Gilead Sciences, Inc.Program year20242 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
45.4%ACE inhibitor24.7%Lisinopril100%Part D<11 patientsStatin20.6%Atorvastatin Calcium100%Part D<11 patientsAnti-infectives
23.7%Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor12.4%Triumeq100%Part D<11 patientsHuman Immunodeficiency Virus Integrase Strand Transfer Inhibitor11.3%Juluca100%Part D<11 patientsNervous system
17.5%gamma-Aminobutyric Acid A Receptor Positive Modulator17.5%Zolpidem Tartrate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 22 Oct 2026
8 NIH research awards on record, funded 2016–2026 per NIH RePORTER. The latest:
- Evaluation of Glucagon-Like Peptide-1 Receptor Agonist on Pathophysiology of Inflammation and Atherosclerosis in Persons Living With HIV: A Multicenter Randomized Placebo-Controlled Tri
University of California Los Angeles
FY2026$1,282,827R01HL184987 - Preparing for Semaglutide Microdosing to Maintain Cardiovascular Health in People with HIV: The (pre-)SMASH CVD Trial
University of Texas Hlth Sci Ctr Houston
FY2026$255,458R34HL182386 - Estrogen's Impact on IgG Glycomic Modulation of Immunity and Inflammation During HIV
University of Texas Hlth Sci Ctr Houston
FY2025$2,461,651R01AI189353
Congress activity
Updated 22 Oct 2026
2 congress contributions (2020–2025) across ENDO per OpenAlex. The most recent:
- SAT-730 Evaluating the Association Between Bone Metabolism Markers and Bone Mineral Density in Men with and without HIV
ENDO Annual Meeting
ENDO2025Co-author - SAT-LB134 Aging Related Changes in Sex Hormone-Binding Globulin in Men With HIV
ENDO Annual Meeting
ENDO2020Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 22 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Semaglutide improves MASLD and MASH in people with HIV: The SLIM LIVER study.
HIV medicine
Clinical Trial2026 - Weight Gain on Contemporary Integrase Strand Transfer Inhibitors and Tenofovir Alafenamide in Persons With HIV Starting Antiretroviral Therapy in the United States and Canada.
The Journal of infectious diseases
Article2026 - A 48-Week, Randomized Controlled Trial of Doravirine for Individuals With HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391).
Clinical infectious diseases
Clinical Trial2026 - Longitudinal Serum Metabolomic Signatures Related to Integrase Strand Transfer Inhibitors-Associated Weight Gain in Women with HIV Enrolled in the MACS/WIHS Combined Cohort Study.
The Journal of infectious diseases
Article2026
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03HIV and antiretroviral therapy-related fat alterationsReview227 citations2020
- 04
- 05Metabolic disease in HIV infectionArticle196 citations2013
Network
Updated 22 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 22 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
med.uth.edu/internalmedicine/faculty/jordan-e-lake-md-msc
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.uth.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 22 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- M.D.
Baylor College of Medicine, Houston, TX
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.uth.edu ↗ - M.S.C. in Clinical Research
University of California, Los Angeles
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.uth.edu ↗ - Residency in Internal Medicine
Baylor College of Medicine, Houston, TX
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.uth.edu ↗ - Fellowship in Infectious Diseases
University of California, Los Angeles
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.uth.edu ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.uth.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.uth.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.uth.edu ↗
Awards & honors
honors on the public record- Barbara E. Murray
MD, Distinguished Professor in Internal Medicine Research
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.uth.edu ↗
Secondary affiliations
appointments beyond the home institution- Baylor College of Medicine
Houston, Texas
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.uth.edu ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →rss.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Myron Cohen, MD
University of North Carolina at Chapel Hill School of Medicine
Derrick W. Crook
John Radcliffe Hospital